SUPERNUS PHARMACEUTICALS INC
SUPNNASDAQ🏆 #1653 by market capEarnings Nov 3US Equity
$46.78▼ $0.10 (−0.22%)
Live1h▼ 1.2%
24h▼ 0.2%
7d▼ 0.4%
14d▲ 0.5%
30d▼ 1.3%
1y▲ 13.4%
🏦Market Cap
$2.71B
Small Cap
📈Revenue Growth (YoY)
+24.9%
Healthy
📊Gross Margin
88.3%
High
💵FCF Margin
17.3%
Healthy
⚖️P/S Ratio
3.3x
Fair
Otter Score
53
Weak
Earnings
Q3 · 2026Reported 2026-08-03Earnings Per Share
Actual
0.54
Expected
0.42
beat
+27.80%
YoY −40.70%
Revenue
Actual
$219.06M
Expected
$205.31M
beat
+6.70%
YoY +32.40%
Consensus estimates
Recent quarters
Q3 2026
0.54
beat
Q2 2026
0.59
beat
Q1 2026
0.92
beat
Q4 2025
1.01
beat